GlassScriptPhysician profile
Ramla Sharif
NPI 1346561677
$518.39
in general payments reported to CMS, 2019-2025
12 companies · $47.07 in 2025
The $47.07 reported for 2025 was less than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.57 · 2020: $17.38 · 2022: $47.11 · 2023: $109 · 2024: $285 · 2025: $47.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.33 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $243.71 | 2022-2024 | Airsupra, Farxiga |
| Lilly USA, LLC | $58.74 | 2023-2024 | Zepbound, Mounjaro |
| Novo Nordisk INC | $47.41 | 2023-2024 | Wegovy |
| Novartis Pharmaceuticals Corporation | $29.95 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $25.00 | 2023 | Nexletol |
| Abbvie INC. | $18.57 | 2022 | |
| Philips North America LLC | $17.49 | 2024 | (Ck7) Extended Holter |
| Fidia Pharma USA INC. | $17.17 | 2024 | Hymovis, Triluron, Hyalgan |
| Almatica Pharma LLC | $17.00 | 2025 | Loreev Xr |
| Merz North America, INC. | $15.58 | 2025 | |
| Amgen INC. | $14.49 | 2025 | Otezla, Repatha |
| Exact Sciences Corporation | $13.28 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramla Sharif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.